Comparison of diagnostic criteria to detect undiagnosed diabetes in hyperglycaemic patients with acute coronary syndrome
- 27 June 2011
- Vol. 98 (1) , 37-41
- https://doi.org/10.1136/heartjnl-2011-300163
Abstract
Background Elevated plasma glucose levels on admission (APG) are very common in patients with acute coronary syndrome (ACS) and can be the first indication of diabetes mellitus. Objective To provide insight into the prevalence of previously undiagnosed diabetes and to compare different methods of diagnosing diabetes in patients with ACS. Methods Patients with ACS with elevated APG who participated in the BIOMArCS 2 glucose trial underwent an oral glucose tolerance test (OGTT) prior to discharge. 130 patients were included who underwent metabolic assessment. Of these, 109 had an OGTT and 13 patients had pre-existing diabetes. Results The OGTT results were categorised as (previously) undiagnosed diabetes in 35% of patients (fasting plasma glucose (FPG) ≥7.0 mmol/l or 2-h post-load glucose ≥11.1 mmol/l) and impaired glucose metabolism in 44% (FPG 6.1–6.9 mmol/l or post-load glucose 7.8–11.0 mmol/l), so only 21% had a normal glucose metabolism. Undiagnosed diabetes could not be adequately predicted with APG, FPG or HbA1c (area under the ROC curve 0.61, 0.75 and 0.72, respectively). Patients with abnormal glucose metabolism were significantly older, had higher admission HbA1c values, a higher Killip classification and more often had a prior stroke than patients with normal glucose metabolism. Conclusion 79% of hyperglycaemic patients with ACS were found to have abnormal glucose metabolism. As APG, HbA1c and FPG had a low sensitivity to detect undiagnosed diabetes, an OGTT appears to be the best test to assess the presence of previously undiagnosed diabetes or impaired glucose metabolism in hyperglycaemic patients with ACS.Keywords
This publication has 18 references indexed in Scilit:
- Intensive management of hyperglycaemia in acute coronary syndromes. Study design and rationale of the BIOMArCS 2 glucose trialDiabetic Medicine, 2011
- Comparison of glucose-insulin-potassium and insulin-glucose as adjunctive therapy in acute myocardial infarction: a contemporary meta-analysis of randomised controlled trialsHeart, 2010
- Elevated admission glucose is associated with increased long-term mortality in myocardial infarction patients, irrespective of the initially applied reperfusion strategyAmerican Heart Journal, 2010
- Poor reproducibility of the oral glucose tolerance test in the diagnosis of diabetes during percutaneous coronary interventionInternational Journal of Cardiology, 2010
- Prevalence and outcome of newly detected diabetes in patients who undergo percutaneous coronary interventionEuropean Heart Journal, 2009
- Current Management of Hyperglycemia in Acute Coronary SyndromesCritical Pathways in Cardiology: A Journal of Evidence-Based Medicine, 2009
- Abnormal Glucose Metabolism in Acute Myocardial Infarction: Influence on Left Ventricular Function and PrognosisJACC: Cardiovascular Imaging, 2009
- Hyperglycaemia in acute coronary syndromes: risk-marker or therapeutic target?Heart, 2009
- Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary: The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD)European Heart Journal, 2006
- The prevalence of abnormal glucose regulation in patients with coronary artery disease across EuropeThe Euro Heart Survey on diabetes and the heartEuropean Heart Journal, 2004